News

Heavy metals in MS

7 December 2016

In a new study published recently, tissue from the MS Research Australia Brain Bank was used. Led by Associate Professor Roger Pamphlett from the University of Sydney, to study the role of heavy metal accumulation in the spinal cord of people with MS and other neurodegenerative disorders.

Motor neurons, the cells in the brain and spinal cord that control muscle function and movement, can be injured and lost in MS and often in areas not affected by lesions. One factor that may contribute to this loss is the uptake of toxic substances from the environment such as heavy metals like mercury or silver.

The research used a technique called autometallography which allows researchers to see whether heavy metals are present within cells. Associate Professor Pamphlett examined spinal cord tissue samples from people with MS, as well as people who did not have any evidence of motor neuron damage. He found that heavy metals were present in motor neurons and also in a special class of nerve cells called interneurons, which relay electrical signals between different types of nerve cells.

It was found that in the normal ageing process heavy metals accumulate in nerve cells. However, if this accumulation was too great, or if people had other risk factors it may contribute to the loss of neurons. In particular, damage to interneuron types of cells can lead to nerve loss, as these cells normally help protect nerve cells, but removing interneurons short circuits this protection leading to nerve cell loss.

The use of tissue from people with MS is key to the success of this study, as only examining nerve cells from the spinal cord, in this case, can help answer the question of whether heavy metals or other environmental toxins are having an impact on MS and other neurodegenerative disorders.

If you would like more information about the MS Research Australia Brain Bank or would like to register to become a brain donor please phone 1300 672 265 or register online at www.msbrainbank.org.au

Related News

MS News

From our CEO

28 October 2026

CEO Rohan Greenland reflects on 30 years of progress in MS treatment and why, amid the current PBAC review, protecting treatment choice and access is vital for the future.

MS News

Understanding MS diagnosis and misdiagnosis

28 October 2026

Christina Applegate’s recent experience has raised questions about MS misdiagnosis. We look at how MS is diagnosed, why misdiagnosis can occur and the progress being made to help people get accurate answers and appropriate care and support.

MS News

Unifying MS – research updates from MSToronto2026

28 October 2026

The latest in MS diagnosis, therapies, clinical trials, care and science was presented at the world’s largest conference on MS and related disorders in Toronto, Canada, in October 2026.

Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Heavy metals in MS